Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
no Phase II or III trials published Most common AOD-9604 side effect / Injection-site reaction (redness, swelling) Most common reported MOTS-c side effect / Transient flushing and mild GI discomfort (anecdotal, not trial-confirmed) Growth hormone axis impact / AOD-9604 does not activate the GH receptor
Clients with clinical deficiency may need four to eight weeks of regular injections to fully restore B12-dependent neurological functions
It screens candidacy honestly, sets realistic expectations grounded in the modest evidence, and tracks progress with body composition and relevant lab work rather than promises
There is no receptor to desensitise on a fast clock, and no acute spike to time around a meal
(2022, December 12)
The shot is quick and easy to repeat often, which is why it works well as a weekly visit woven through a longer-term plan
